Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Consider this. Remember KBLB was being privately financed until early 2008. So until those privately purchased shares hit the market, no volume was possible. Yes volume went up from the Split announcement moving forward, but that does not mean the split is responsible for it.
Volume would have increased with or without a split, as shares hit the public market.
Like I said, I dont think there is anything unattractive about owning a 25 cent stock that turning it into .025 will remedy.
Per my personal beliefs, I base it on the promotions at the same time and comparing other f/s pr's from pennies and non pennies. Some of the language is the same, but nowhere have I seen a big boy stock call a f/s a dividend and/or reward for shareholders.
Here is where I see you being wrong.
from the day of conception till they announced the split,
the 90 average volume/price is about 35000 shares a day. At .20 a share the dollar volume was about $7000 a day.
Between the time of the split and the CSC s1 the average volume was around 600K a day at .015 is $9000 a day
From the date of the S1 for the CSC agreement till june of 2010 before the breakthrough announcement the volume is about 125000 a day. At .012 that is about $1500 a day.
So the split increased the dollar volume and liquidity.
The CSC deal was greeted by the market like any other dilutive financing. Volume dropped and so did the PPS.
The fact that Kim got financing was actually a hint to the market that they were going to announce the breakthrough but it can only be seen in hindsight.
The market took the S1 as a "typical pink" and reacted accordingly.
I know one thing. Liquidity is not mesured in volume it is mesured in potential volume. With that in mind...
Prior to the split there were only 49 mil shares which Kim had 33 mill of.
The float was only 16 million.
If they had to make the same deal with CSC without the split (8.8M shares) the float in public hands would have been about 7 million shares total.
That is not enough to be liquid at .15 a share.
The entire public float would have been around a million bucks on a good day and half that on a dip.
As for your personal view you can think it all you want. I dont think you can show the "fake" volume. There is no such thing as "fake" volume (unless you are talking naked short selling.) Can you please explain how any volume can be faked by the company doing a split?
The fact that in the 3 years since the split we have only had a 20% increase in shares is proof beyond a doubt that this is not about fake volume, selling shares to buddies, scamming shareholders, or any other such "typical" penny stock qualities.
My personal view is Kim is actually doing exactly what he claims and is doing it against the grain of what a "typical penny player" expects. Like most human nature, it is common to condem something you see as different to the norm. That happens here a lot.
I know that if KBLB fails it will not be because they never tried.
It wont be because Kim was trying to fraud or trick anyone.
It will be a failure that happens in business sometimes. But I SERIOUSLY doubt Kim will fail at this. He is too skilled in the areas he needs to be skilled in and the product itself is a no-brainer. IMO Kim can not fail.
Thank you for the excellent DD!
RE:"The inner core of dragline silk is made up of a set of tiny fibers called fibrils, which, at the atomic level, organize into two different regions. The incredible strength of the material comes from crystalline lattices that compose roughly ten percent of the total webbing, while its elasticity is the result of so-called “amorphous” regions that make up the remaining 90 percent."
That is, IMHO, a very strong indication of how exceedingly difficult it would be to mechanically spin spider silk. IMHO, K BLB has very little to fear from competition like Amsilk.
I strongly suspect that the third very small spider silk protein is mainly responsible for the structure of the inner core. This indicates why we may not see results for a silk composed entirely of spider silk proteins (I. E.: With no worm silk proteins that all) until all three spider silk proteins have been incorporated. it is entirely possible although very far from certain that an intermediate silk which lacks any worm silk protein for one silk protein and lacks any spider silk protein for another of the three silk proteins*1 will have very poor qualities due to inter species incompatibilities for the proteins. That, of course, would be totally inconsequential for the development of spider silk. But it might be a good reason for not wanting to announce intermediate results for the following reasons:
1) failure to make any comment at all on the qualities of an intermediate result might receive a very negative interpretation.
2) a statement that the qualities were insignificant as this was only an intermediate step in development might receive a similarly negative interpretation.
For the above reasons, IMHO, it would be highly inappropriate to give a negative interpretation to a failure to get a PR on results of an intermediate step.
That could be, for example, the reason that we have not heard any results from the zinc finger insertions made in January.
This is a multistep process. We do not know how many steps it will take, nor which steps will be made, nor in what order. Under these circumstances patience is an unavoidable requirement unless you choose to just exit the stock at this point and forgo any potential gains.
Major news could come at any time: either news of a deal or news of an intermediate step that resulted in a significant improvement to the fiber (note that while I said an immediate step might have poor qualities, that is far from certain, and it is entirely possible that an intermediate step might result in superior qualities which would merit a significant increase in share price: although intermediate step the long-term development such an improved quality would establish a new and higher worst case scenario, I. E.: Even if it turned out that this is the best we were going to get it's still a highly marketable and valuable product.
IMHO, the period during which KBLB was a "traders dream" (fairly predictable time frames for new news with little possibility of intervening news) is now over. I would expect this to result in a replacement of traders by investors. IMHO this is largely responsible for the recent drops in share price. The end result, should be a more stable floor for the share price and lower volatility albeit at the probable expense of lower volume and liquidity (which would have the effect of hastening the exit of traders).
This situation could, of course, end at any time with news of a deal or of insertions resulting in significantly higher quality of silk. In any case it is, IMHO, unlikely to continue for more than a few months. While this may result in a slightly higher rate of dilution, the total effects would probably not be all that significant. Should KBLB ultimately succeed such an episode would almost certainly be considered fairly inconsequential. For that reason I would suspect that far more traders and very short-term investors will be exiting than intermediate or long term investors.
ALL very much JMHO.
-----------------------
*1 lacks a complete set of all three proteins for either species.
EXCELLENT articles!
Thank you DoD
TEC: This should be at least stickied and some of these references perhaps added to the ibox.
Mike L.
Some more, didn't feel like doing any work today :)
Semi-related
http://phys.org/news/2012-05-silkworm-materials.html
Fame-whore Randy back in the thick of it:
http://phys.org/news/2012-05-untangling-mysteries-spider-silk.html
Not about spider-silk but about the structural qualities of regula silk cocoons:
http://www.reuters.com/article/2012/05/02/us-science-silkworms-idUSBRE8401OU20120502?feedType=RSS&feedName=scienceNews
About us (although we don't get a mention):
http://www.abovetopsecret.com/forum/thread793889/pg1
A few interesting related articles:
Silkworm Created with Spider’s Genes
A group of scientists from China and the U.S. has created a silkworm that can spin strong silk.
They achieved this by injecting spider's genes into the silk worms.
According to the researchers, the silk spun by the hybrid silkworm is five times stronger than steel and three times tougher than Kevlar.
The hybrid silkworm contains spider's silk protein which makes it more suitable for making bandages and bullet-proof vests.
"Silkworms are the current biological source of silk sutures, but spider silk fibres have superior mechanical properties that are ideal for procedures requiring finer sutures, such as ocular, neurological, and cosmetic surgeries." Professor Don Jarvis of the University of Wyoing was quoted as saying by the Mail Online.
Earlier, when they had found that the spider could give much stronger silk, the scientists implanted its silk genes into various living things like bacteria, tobacco plant and goats. However, they didn't get any good results.
The researchers found it quite difficult to conduct research on spiders because of their aggressive and cannibalistic behaviour. And at last, a positive result has come in the form of the hybrid silkworm.
Source: International Business Times, Thu, 5 Jan 2012
Genetically Modified Silkworms Produce Super Spider Silk
Spider silk is one of the toughest materials and adaptable materials around. Spiders use this wonderfully flexible material to trap and crush prey and build durable webs. It's strong and elastic enough to stretch several times its original length.
Because of its enticing properties, spider silk could be used for a variety of practical applications like surgical sutures and body armor. Unfortunately producing mass amounts of the material that will make these spider-silk items is problematic. Farming spiders to produce silk isn't as easy as caring for sheep to produce wool. Spiders are territorial and cannibalism is a very serious concern. Spiders also don't produce enough silk to make spider farming a viable manufacturing approach. It would take 4 years and 1 million large spiders to make a piece of cloth that measures 11 feet by 4 feet.
The alternative is to make spider silk artificially. This method hasn't been successful as well. Scientists have cloned a number of spider silk proteins but they've only managed to create small amounts of the material. It's even harder turning the proteins into silk fibers. Now researchers have hit on one novel solution: use another animal that produces silk to produce spider silk.
Scientists from the University of Wyoming have genetically engineered some DNA with spider silk genes and injected them into the silk making glands of silkworms.
"Our hope was that by embedding spider-silk protein [gene] sequences within silkworm silk [gene] sequences, we could get those proteins to co-assemble ... into composite fibers and that is what happened," study co-author Don Jarvis, a molecular biologist, told National Geographic.
Silkworms are easy to farm and can be grown in bulk. Silkworms also have massive glands that turn silk proteins into fibers. While silkworms produce commercially appealing silk it doesn't have the strength and toughness of spider silk. The researchers inserted a hybrid DNA that had a central core from a spider silk protein with smaller fragments of a silk worm protein into silkworm eggs.
The process worked and the genetically modified silkworms produced silk that was 96 to 98 percent silkworm with 2 to 4 percent of fiber proteins coming from spiders. Even though the modified silkworms only produced a small percent of spider silk, the hybrid silk was still twice as tough as natural silkworm silk.
The team is working on taking the silkworm proteins out of the silk fibers. "The next step will be to produce silkworms that produce silk fibers consisting entirely of spider silk proteins," says Jarvis.
If the team succeeds, the stronger silkworm silk could be used in the medical sector for stronger sutures, implants and ligaments. The tougher silk could also be used as a substitute for toughened plastics.
Source: International Business Times, Thu, 5 Jan 2012
Item: 8OGE.03946DFB.AE19C0DB
The spider and the silkworm
There are silkworms right here in the U.S.A. that spin combo silk-spiderwebs. If you don't believe me, believe the Proceedings of the National Academy of Sciences, where this report appeared recently. Why it was not on the front page of this very newspaper is beyond me. Spiders! Worms! Silk! There's something for everybody.
Plus, you can alarm children by telling them about the mutant silkworms with little chunks of spider DNA that are now spinning silk "stronger than steel" in order to, what, capture bad guys? Or rob banks? Oh, it's a comic world that we live in.
The problem the worm-oriented scientists were trying to solve was this: Spiderwebs are ever so much stronger than silkworm silk, and yet attempts to harvest spiderwebs (for a nice spiderweb blouse, perhaps) have met with failure.
"Regrettably," said one researcher, "the spiders tended to eat each other." The article added: "To get spider silk without cannibalizing spiders, several research teams have engineered cells and even goats to produce spider silk proteins. But that leads to a problem: how to spin that protein into large quantities of silken threads."
So it could have been worse - it could been a goat-spider combo. That's really what you want - a hairy, eight-legged thing the size of an end table spinning traps to ensnare the unwary, which would certainly mean me and probably you ending up in the maw of the goatder.
So the scientists had to enlist the help of the reliable old spinner Mr. No-Threat-to-Anyone, the silkworm.
The researchers came up with the notion "How about if we put some of that zesty spider DNA in with the silkworm? Then perhaps we will produce a new wonder apparel product." Or, of course, a silkworm that suddenly decides to weave traps instead of cocoons. This is where all the testing and the computing and suspicious lab fires and the disappearance of the town of Crawford, Neb., come in - perfecting the mutant worms while inadvertently doing annoying things to the mutant spiders.
According to the website Live Science, " 'All of those platforms allow for protein production, but then they have to find a way to transform those proteins to fibers,' said Donald Jarvis, a biologist at the University of Wyoming who led the research on the silkworm-spider blend."
Anyway, now it is done. Test garments have been woven from test threads. It's only 5 percent spiderweb, but it's still 48 percent stronger than silk. You can't buy it yet, because, I suspect, the developers are coping with scaling up the project so it can produce more T-shirts than China.
This reminds me of a fable by Aesop called "The Silkworm and the Spider." It goes like this, as related by somebody on the Internet:
"Having received an order for twenty yards of silk from Princess Lioness, the Silkworm sat down at her loom and worked away with zeal. A Spider soon came around and asked to hire a web-room nearby. The Silkworm acceded, and the Spider commenced her task and worked so rapidly that in a short time the web was finished. 'Just look at it,' she said, 'and see how grand and delicate it is. You cannot but acknowledge that I'm a much better worker than you. See how quickly I perform my labors.' 'Yes,' answered the Silkworm, 'but hush up, for you bother me. Your labors are designed only as base traps, and are destroyed whenever they are seen, and brushed away as useless dirt; while mine are stored away, as ornaments of Royalty.' "
Well, I think I'm feeling sorry for the spider right now. If I didn't know she had a tendency to eat other spiders, I might think that this was a tale about bullying, and in the end a goatder would come and make the silkworm see reason.
And since when is ornamental better than useful? Isn't Aesop the champion of the common man, of the ant who methodically engages in utilitarian tasks his entire life? How does that square with "ornaments of royalty" and all that hoorah? Is that how we are to be judged, on our ability to produce baubles for rich people?
Never mind; don't answer that question.
I can't wait to be the first person on my block with a silk-spider blend. I worry about the stickiness factor. Maybe you'd walk through a room and every piece of lint would suddenly adhere to your shirt. But I'm sure they've thought of that. They did, after all, create the famous goatder.
The terrible tale of the cannibal, the Wyoming scientist, the miracle fabric and goats.
(C) San Francisco Chronicle 2012
Some DD on spider silk....................
Not so new:
http://www.infoworlds.net/spidergoat-popsci-article/
Not about us but about a bunch of people that wishes they had never bothered undertaking this project:
http://www.ispyanimals.com/2012/05/move-over-silkworms-spiders-coming.html
http://thecarbonworks.com/blog/?p=1104
Somebody is in for a shock,
True, but it makes no difference whatsoever to my point:
RE: "most of the reaction of a split actually happens before the split. "
Whether the reaction to a split comes after the news and before it's actually implemented makes no difference whatsoever: the actual split itself has no impact whatsoever on the long term or intermediate term price. (10 X 1)/10) is still exactly the same number as 1, and (1/10) X 10 is still exactly the same number as well (substitute any other number for 10).
What is significant (OR NOT) are the reasons (or lack thereof) for the split.
most of the reaction of a split actually happens before the split.
In the pennys people pile on to a FS and increase the PPS the FS happens and the PPS drops but it does not always drop to where it was before the split
example..
a .10 stock announces a FS of 1:1
People pile on and the PPS goes to .15
FS happens and the PPS drops to .075
The actual PPS value before the FS was mentioned was .10 so the PPS should actually be .05 but there is .025 added value to the PPS.
The post split sell off drops the PPS to .06.
In the end the FS actually increased your PPS by 20%
A RS does the same thing backwards.
It is hard to find a RS that the PPS does not crash on when announced and lower the PPS after the RS is done.
I know the numbers here are all just for use in an example but a FS or RS can definitely effect the PPS long and short term.
In Our case we were around .20 the PPS increased about 75% for 5 months following the announced split in March 2009. It did not return to its "normal" price till August 2009. That was when this stock became a stock to flip and the PPS minipulation started.
All IMO
I agree with this statement Ray...
Splits, whether forward or reverse, have no long term (or even intermediate term) effect on the SP in and of themselves.
They MAY have a very short term effect because of market misinterpretation of their relevance. That is only because the market attaches a USUAL meaning to spilts. But if time shows that the split was a "bluff" (i.e.: that the usual reasons were not there) then the SP will return to what it would have been without the split (with a possible overreaction due to suspicions of why such a bluff would have been done.)
If the SP was not going to go to some amount of increase or decrease, a split will have absolutely no effect on such a trend whatsoever, except for a possible short term movement that will quickly correct if there is nothing real behind the split. If there IS something real behind the split, then IT is what is responsible for subsequent SP movement and not the split.
THINK abut it!: if splits had any power in and of themselves, they would be far more frequent than they are!
I was the one who made the comparison. I have said it was solely in respect to what the SP might do in response to big unexpected (at least as to timing) news. So please don't hold me responsible for any further comparisons you want to make, because that does not involve me. OK?
Just because I posted a chart in no way holds me responsible for any and all comparisons you might want to make from it! With that standard of relevance, no one would ever be able to find ANY example to meet it.
I think the reason for the FS here is pretty obvious if you look at the historical PPS. Back pre-split we were trading at a 10 day avg volume of about 500 shares @ .30
There is no way to get financing for shares with that lack of liquidity. the split made us a low penny stock and allowed us enough shares to create volume and therefore get financing.
I would not loan money to a company for shares when I look and find out that the million shares I have will take me 15 years to sell off and I will crash the PPS with the first sale of 5000.
You are 100% correct mathematically that a split does nothing to your wallet but it is about 99.99999999% sure that a PPS after a split will automatically begin to reach for the PPS it was at prior to the split.
A FS of 1:1 would make a $1 stock .50 but the price would begin edging up towards the dollar PPS again and the same for the RS. PPS goes from .50 to $1 and Post RS the PPS heads back to .50.
I believe Kim would have never got started without the FS
Quick note about forward/reverse splits for all.
1. They are used to control the share price.
2. Charts account for them, which is why you see a seemless transition(now) pre-split to post-split. Those pre split numbers are NOT what xyz stock traded at pre split. As there (post split) is a (in a f/s) higher O/S, the $ trading is still represented correctly.
Splits are not a reward. You do not overnight become ten times richer. Or in the case of a r/s the opposite.
F/S are seen to be bullish however. And used to control a share price deemed to be too high.
How much volume would there be in KBLB if there were 2 shares, and each costed ~20 million?
I still see no reason for Kim to have done a F/S.
Good Luck!! I am not that stupid..
Nope. never gonna happen. you should sell
Does anyone believe there wiil ever be great news for KBLB?
I agree with you that big news can make a pop. I just dont compare companies unless they have something very similar in common. I could show a dozen penny stocks a day that move on big news. I dont care about buy up moves I worry about big down moves. The example you gave is one I would run from.
Show me the DuPont chart from 1965 to present. That was when they had Kevlar for the first time. Since then they have 3 splits of 3:1 and the PPS is up 500% on top of that.
That is a chart I want to see for KBLB not a spike.
But it still doesnt compare.
I can not find something like KBLBs potential because there is none. I can not find a new textile that was premiered by a publicly traded company with nothing else behind it. You cant look at DuPont because they have much much more then Kevlar. Kevlar only accounts for 25% of their sales.
Other fibers are not new or are not owned by any one company.
The closest you can get is a pharmaceutical company. But they just need the hope f sales to pop. We will need actual sales.
Hopefully soon. I could use the excitement.
You said we were supposed to have a "significant gap up" upon news of successful ZFN insertions.
That came in November, no gap up.
The market is looking for something specific, and "big news" is ambiguous at best.
You should not always take King seriously. He is joking when he gives extremely vague answers. A Friday does not mean next Friday.
You are greatly over extrapolating my example from what it was given to show. I gave it ONLY as an example of the kind of very sudden short term movement that could happen to KBLB upon big news.
Any other interpretations or comparisons are your own, not mine! As you said, no two stocks are alike so comparisons are limited to some aspect under discussion (in my case the reaction of the SP to "out of the blue" (i.e.: timing not foreseeable) big positive news.
Let's all remember to honor those that have served in the past and are currently serving our country. A smile and a sincere thank you.....pick up a dinner tab....buy a drink....remember their sacrifice.....Freedom Isn't Free!
Thank you
that is my point. There is no way to compare KBLB to any other stock. no 2 are alike.
the bottom lime is 99.9% of shareholders in the otc are not investors. They will not buy a stock long term. If there is no volume there will be no price movement. Until there is news there will be only the price movement of people with a lot of money pushing their chosen cash cow around until news makes it impossible to control the PPS.
I am willing to wait because my average does not make me feel threatened. The powers that be cant get the PPS down low enough to threaten me. Some people like you have a higher PPS average can be talked into or out of their shares during low volume times. I think that is why we have a lot of "wheres the news" posts. Too many people here that are not long term holders so they can feel threatened by the PPS drop.
My advice (as always) is buy more. I have faith in KBLB so that is always my advice to people who are not in. To people who are in I say learn the PPS movements and ride along while you are waiting and collect more shares on the flip. In the long term every share you can collect now will be a big pay out when the PPS can no longer be manipulated.
Bad example....2 R/S's 1 for 4 and 1 for 15 which equates to 1 for 60........unfortunately I KNOW from personal experience
Not sure why you chose that stock ZF but I think it is a poor example. I do have to say the chart looks a lot like KBLB though.
The problem is it only looks good if you look at the short term. Try looking to the 3 year chart you wont be so impressed. Yeah it had a nice pop from $2 to $16 That is the same as us going to .40
But 3 years ago the PPS was 400+ and it dropped to $2. That would be the same as us dropping to .002 (yes I know they had a couple of small splits but that is not the reason the PPS is so far down)
Like KBLB they have a substantial drop to clear up before they get back to where they have no complainers. Their little pop is not even a start
Doesnt matter at this point what might happen. I do not expect any movement but down until they make a deal. Kim has trapped himself. If Kim announces a deal we will pop and start trading like a normal stock. But now that he has claimed commercial ramp up the PPS will do nothing but drop until he produces what he says. At this point even flipping is senseless. You are either in or out.
My average cost basis (like Mike), is just over .09. If I was holding at less than .02.....I'd be doing cartwheels!
Hi Mike,
I have been holding KBLB and many other securities long before I ever joined this message board.
It took me over 12yrs. of being in the market, before I ever became involved with boards.
I have been here 3 years too Carry and I dont understand how you can ask the questions you do. If you have been here for 3 years you bought in at a penny or maybe .015.
You dont need any patience and your constant questions about the PPS popping have been answered. Congrats you are up 400%.
Now you dont need to ask anymore. You can sell and be happy you made a profit.
Hi Bob,
Thanks for the info. regarding your email to Ben.
Officially, what date are you using as the date that your patience ran out?
Hi Romans..
I totlly agree with your guess of two months OR SO. I wanted to tell you that I emailed Ben about six weeks ago, and he told me that there is no reason why commercialization could not begin this year.
Therefore, I agree with you that two years is an unrealistic forecast and that something is coming sooner than later....
K.T. knows. Based on all of the information we have been privy to, I think a 2 year time frame is highly improbable....a much more realistic GUESS would be WITHIN 2 months. IMO
GLTU
Maybe two years from now, but who knows if the news will be positive
Carry, We will have BIG BIG BIG BIG BIG BIG news end of day on a Friday! :)
Where is the news? I have been patience for 3 years...
Manshoon,
I concur that your evidence is true and Zinc is wrong. However I agree with Zincs conclusion about the matter as being dead. People have attempted to throw doubt at my evidence before and I do take that personally
Absence of evidence is not evidence of absence. Especially when the evidence hasn't had adequate time to surface.
Patience is required. Check out a chart of ROSG to see what the payoff for patience might be. Note the SP behavior immediately preceding the big news. Charts give no warning whatsoever (and are inherently incapable of doing so) of big news events. If KBLB gets a deal we will almost certainly see something similar.
http://finance.yahoo.com/q/bc?s=ROSG&t=3m&l=off&z=l&q=l&c=
(This posted purely as an example and is NOT a recommendation to buy: buying ROSG at this point entails a real risk of a very substantial pullback! The way to avoid that risk (and to get maximum increase) is to buy before the news.)
Thanks Zen,
I don't know how you do it, do you have a software to comb for any piece on KBLB and spider silk?
Appreciate the effort.
Among the scores of exhibitors 6 were asked for their input. Doesn't it say KBLB created quit a stir !!!
We had this whole discussion about how the booth looked amateur, duct tape and all, there was no need for them interview Kim from among the high high rollers.
They probably picked the busier ( hence happier) exhibitors for this article, so as to creat the hype for the Anaheim Show next year.
Don't know who is using whom, but Kim did make the right decision of attending. Duct tape and all !
Very Cool Zenaku. Thank You.
I agree completely.
There are only a few people that are on the inside in kraig. And what your talking about is insider trading. It would be an easy thing to spot if someone made a couple million dollars on a small investment in a very short period. That trade would be caught.
You mean WHEN KBLB does that? :)
If we had the goods, wouldn't the word leak out? Billon dollar companies already working with us and new ones now shopping. If any of them believed that we had the holy grail, wouldn't they want some. I would expect new investors with deep pockets. No new blood here, just the same old same old. Penny stock warriors trying to out do each other...
Sorry DoD, no PM... Yes that is it though. It went through the roof this month. I wish I had a better grasp of the fundamentals. I would have gotten in on it. Can you imagine KBLB doing that?
Zincfinger you are wrong. When reading the supplied links it is VERY clear what was referenced. Especially when looking at the post replied to! The statement from dr Kaplan is legitimate.
I don't care what position one takes, as long as it is taken noting what was said by Kaplan, hansel, and Fraser.
I still have the dr Kaplan email in my inbox.
Zinc finger, if the standard of proof was the same across the board, then how do you "know" that Dr Kaplan is not on KBlB's advisory board ? Please show me the proof for the statements you have made.
The truth is on my side, and I don't care if I stand alone.
Followers
|
632
|
Posters
|
|
Posts (Today)
|
11
|
Posts (Total)
|
276125
|
Created
|
05/04/08
|
Type
|
Free
|
Moderators MU_Redskin1 gimmegimmeminemine TRUISM EOT WebSlinger |
Email: corporate@KraigLabs.com
KRAIG LABS WEBSITE FOR INVESTORS
Quarterly and Annual Reporting to the SEC is available on the Company's Website and EDGAR.
* Financial Statements * SEC Filings *
Outstanding Shares as of January 12, 2023
For issues or questions relating to share certificates or the transfer of securities please contact the company's transfer agent:
Olde Monmouth Stock Transfer Co., Inc.
200 Memorial Pkwy.
Atlantic Highlands, New Jersey 07716
Phone: (732) 872-2727
(since August 14, 2013)
Kraig Biocraft Laboratories, Inc. (KBLB) is the first company with a commercially feasible spidersilk to be mass produced.
Kraig Labs is a biotechnology company focused on the development of commercially significant high performance polymers and technical fibers. Kraig Lab's focus has been on the production of a transgenic silkworm incorporating specific gene sequences from the golden orb weaving spider. These specific gene sequences inserted are to enable the silkworm to spin a new recombinant fiber which incorporates spider silk proteins. With the scientific breakthrough announced on September 29, 2010, Kraig Labs is now working to commercialize the transgenic silkworms to compete in the garment industry silk market. The value for the chinese raw silk market alone is 3-5 billion per annum. With the creation of 20 seperate transgenic silkworms, all with unique properties, Kraig Labs is now working at an accelerated pace to build upon their first generation transgenic organisms to develop their second generation of transgenic silkworm incorporating spider silk proteins. The scientists nearly doubled the strength of the silkworm with these specific spider gene insertions. Their second generation of transgenics are expected to be complete in 2011. These second generation organisms are to be compared with the strength, flexibility and resiliency of the native spider in which the gene sequences are derived from. These fibers which will match the strength of spider silk are expected to compete in the technical textiles market valued in excess of 120 billion per annum. The 3rd generation organisms are currently in the planning phase. These organisms are expected to spin fibers exceeding the strength of native spiders and may incorporate gene sequences that release an antibiotic, or to help reduce scarring with use in bandages.
Kraig Biocraft Laboratories has a sponsored research and development program with the University of Notre Dame, and the University of Wyoming. The genetic work is occurring at the University of Notre Dame, headed by Dr Malcolm Fraser, Phd. The gene sequences are derived from Dr. Randy Lewis's(University of Wyoming) patented gene sequences of the golden orb weaving spider. Kraig labs is paying for all expenses incurred for this research and development program, and thus Kraig Labs has exclusive global commercialization rights with the technologies developed, including methods, organisms, and fibers produced.
MANAGEMENT
Kim Thompson, Founder and CEO
As the CEO of the company, Mr. Thompson is the only member of the scientific advisory board who is also
a part of the corporation's management. His formal education lies in the fields of economics and law.
He received his B.A. in Applied Economics from James Madison College at Michigan State University.
He received his Juris Doctorate from the University of Michigan Law School in 1994.
Mr. Thompson founded Kraig Biocraft Laboratories in his pursuit of the development of new biotechnologies
with industrial applications. As chairman of the scientific advisory board, he brings a unique perspective,and
acts as the primary liaison between the advisory board and the corporation.
Mr. Thompson brings a wealth of experience in business management and consultation to Kraig. Following
the completion of his undergraduate degree, Mr. Thompson joined California Craftsman, Inc. as a
Vice-President with primary responsibility for both marketing and human resources.
Kim Thompson was the director of business development at Franchise Venture Partners, LLC. He subsequently
joined the firm of Shearson, Lehman, Hutton where he specialized in equity trading and research of small cap
companies. Mr. Thompson received the highest series seven score for all Shearson brokers in his class nationwide.
His experience in those small cap equity markets has proven to be invaluable both in his legal and business successes.
Prior to becoming a public company CEO, Mr. Thompson was the founder and senior litigation partner in a California
commercial law firm where he worked as corporate and litigation counsel to privately held and public companies.
His many accomplishments in corporate law include winning and collecting in full what his firm believes to have been
the largest award of lost profits in a California commercial arbitration up to that time. An important part of his work was
winning victories on behalf of corporate clients in disputes over intellectual property and distribution rights. He has
represented business clients ranging from small start ups and micro caps to Fortune 100 companies.
With a background in business leadership and in advising public and private corporations, Kim Thompson continues
to bring a unique perspective to the successful management of business. His extensive business and legal background
enables him to create practical solutions to business problems and seize opportunities for growth.
Mr. Thompson is a member of the Triple Nine Society for persons with documented genius level IQs (having tested above
the 99.9th percentile). He is also active in the realm of science and invention where he has to his credit a number of
provisional patent applications including innovations in the areas of biotechnology, organic polymers, genetic engineering
and magnetic field manipulation, among others.
Mr. Rice has over 13 years’ experience growing development stage businesses with a focus on technology development, commercialization, and go to market strategies. Mr. Rice holds a B.S. in Chemical engineering from Michigan Technological University.
Prior to joining Kraig Biocraft Laboratories Mr. Rice was the Director of Advanced Technologies for Ultra Electronics, AMI. In this role, Mr. Rice was responsible for the identification, capture, and execution of new technology programs. During his tenure with AMI, Rice secured more than twenty five million dollars in funded development programs from the US Department of Defense which his team successfully leveraged into commercially viable spinoff products. Mr. Rice was also responsible for technical sales, marketing, and promotion of AMI’s products and capabilities. Rice joined AMI as the third full time employee and helped to lead the organization through its rapid growth and ultimate acquisition by Ultra Electronics in 2011.
Earlier in his career Mr. Rice developed unique advanced manufacturing techniques, established and trained a production staff, led engineering development, authored numerous technical papers, and is a recognized subject matter expert. Mr. Rice holds 5 issued patents and numerous provisional patents.
Mr. Rice brings a history of transforming revolutionary ideas into viable commercial products.
Mr. Rice is currently completing his Masters of Business Administration through the Executive Program at the Eli Broad College of Business: Michigan State University.
Despite the huge potential of genetically modified animals outside of laboratory research, commercialisation of these animals has been extremely limited. Numerous factors, including negative consumer perception, regulatory hurdles, and limitations inherent to classical GM technologies, have kept the majority of GM animal applications within the realm of academic research. However genome editing using zinc finger nucleases could help develop new markets for the future commercialisation of GM animals.
Genetic modification is commonplace throughout the life sciences sector, from fundamental research to pharmaceutical testing. GM cellular and animal models are valuable tools for the study of many chronic diseases, the testing of pharmaceutical compounds and the development of new therapeutic strategies. Genetic modification also offers great benefits in vaccine and biopharmaceutical manufacturing, which rely heavily on the use of GM organisms for biomolecule design and production. Modifying the genome of an organism or cell line allows the incorporation of target biomolecules in specific biological contexts, as well as the transfer of a gene product from a low-producing organism to one that can produce on a commercial scale. These applications have been widely accepted for many years, with countless GM organisms approved for medical manufacturing applications by drug regulators in all major countries. Despite this widespread success within the research and pharmaceutical sectors, the use of GM organisms outside of these markets has been limited.
Despite the lack of broad acceptance for most commercial applications of GM animal products, this technology has been able to gain traction in a few market sectors. The most obvious application has been the commercialisation of transgenic animals for the production of biomolecules for therapeutic use. Cattle, sheep and goats have been used for large-scale production of antibodies, steroids and hormones - most notably insulin - for many years. In 2009, GTC Biotherapeutics received US FDA approval for bioproduction of a recombinant human antithrombin. This product - ATryn - is extracted from the milk of transgenic goats, and is the first approved biopharmaceutical to be produced using genetically engineered animals. Although this is a significant breakthrough for the commercialisation of GM animals, it is still within the pharmaceutical industry, and is a natural progression of existing cell-based technologies. Of potentially greater commercial interest is the extension of genetic engineering outside of this sector, into areas such as food production, textiles and even companion animals.
GM crops have been available in many countries since the early 1990s, and numerous cash crops - including sugar beet, soybean, corn and tomatoes - have been modified to improve resistance to disease, increase the rate of growth or enhance nutritional value. However, cultivation of these transgenic crops is generally tightly regulated, particularly within the European Union, and this, together with negative public opinion, has limited the more widespread development of GM technologies.
Similar to GM crops, many of the animals currently under development are intended to confer disease resistance, an application particularly suited to the use of zinc finger nuclease (ZFN) technology. Many diseases can be treated by the targeted deletion or modification of a host gene. With ZFNs, these targets can be modified with no footprint of genetic engineering. Due to the high costs of raising livestock, another area of focus in developing commercial GM animals has been increasing the rate of growth or size of animals. Among the first GM animals likely to be launched is a fast growing salmon from AquaBounty. The AquAdvantage Salmon is designed to reach market size in half the time of a wild type salmon, reducing costs for fish farmers and limiting the environmental impact of salmon farming by avoiding the need for ocean pens.
Although genetic engineering of animals for food is primarily driven by economic pressures, GM technologies have also been used in the companion animals market. In this sector, genetic modification can be used for practical purposes - such as the creation of hypoallergenic animals or the correction of heritable congenital defects which have arisen though inbreeding - or for purely cosmetic purposes, such as GloFish. The first example of a GM pet, GloFish are fluorescent zebrafish (Danio rerio) that have had genes encoding naturally fluorescent proteins (GFP, YFP, RFP) inserted into their genome. Developed by a group at the National University of Singapore, GloFish were originally created to develop live detection systems for water pollution. They were introduced as pets in the United States in 2003 following over two years of extensive environmental research and consultation. In Europe however, the sale and possession of GloFish is prohibited by rigorous legislation concerning the use of GM technologies.
By allowing precisely targeted insertion of spider genes and concomitant removal of endogenous silkworm silk genes at the same locus, ZFN technology offers the potential for development of transgenic silkworms which will produce native spider silk at commercially viable levels
Perhaps even more interesting from a commercial perspective is the use of GM animals in the manufacture of textiles. Silkworms - actually the larval form of the silkmoth Bombyx mori - have been used for the production of silk for thousands of years, with natural silk still produced by the cultivation of silkworms today. Silkworm cocoons are unwound to create linear silk threads, then re-spun into textiles in much the same way as cotton. Although the applications of silkworm silk are numerous, due to their unique physical and chemical properties, there is also widespread interest in the silks of several other insects.
Spider silk, in particular, offers numerous possibilities within the technical textiles industry, due to its incredible tensile strength and elasticity; characteristics which have not yet been replicated in synthetic materials. Like all insect silks, spider silk fibres consist of repetitive units of protein crystals separated by less structured protein chains. The exact properties and composition of each spider silk vary with its intended function. Major Ampullate or dragline silk, for example, is relatively hydrophobic with very high tensile strength and toughness, as it is used to form the outer rim and spokes of a web. In contrast, hydrophilic capture spiral silks, which form the inner structures of the web, are sticky and highly elastic to effectively entrap prey. This high degree of variability offers enormous potential for the textiles industry, raising the possibility of tailoring the properties of silk to create advanced technical fabrics, for applications such as bulletproof vests, parachute canopies and automobile airbags; biomedical applications, including sutures and tendon and ligament repair; new fabrics, for sportswear and clothing; and even microelectronics.
Although the use of spider silks for microsutures has recently been reported, more widespread application of spider silk technologies is currently limited by the difficulty in producing silks on a commercially viable scale. This is due to the difficulties of rearing spiders in large numbers, due to their highly territorial and cannibalistic nature. As a result, the harvesting of spider silk fibres is extremely time consuming and labour intensive, with production of the only known spider silk garment - an 11 foot by 4 foot shawl made from golden orb spider silk - taking 150 people over five years to produce and costing in excess of £300,000!
.
To overcome these limitations, and allow future development of spider silk technologies, an alternative strategy for spider silk production is required. This makes spider silk production an obvious candidate for genetic modification, inserting spider silk genes into the genome
of other silk-making insects for bioproduction. For example, random insertion of orb spider silk genes into silkworms has allowed production of hybrid spider/silkworm silk using traditional silkworm farming strategies. The resulting hybrid silk contains approximately 10% spider silk
and has greater strength and durability than native silkworm silk, raising the possibility of using transgenic silkworms to produce pure spider silks.
Though straightforward in principle, the exchange of native silkworm genes for spider silk genes, alongside more widespread exploitation of genetic engineering, has been limited by the inherent restrictions of conventional GM technologies.
The generalised process of modifying an organism requires several capabilities, including:
While many different techniques exist for accomplishing each of these steps, most GM technologies offer a compromise between the efficiency of the technique and the ability to accurately and precisely target the locus of interest. Viral genomic delivery technologies effectively deliver nucleic acids to cells and organisms, but fall short on ability to target specific regions of the genome, generally only allowing random insertion of genetic material. In comparison, transposase technologies allow a greater degree of targeting, but leave unwanted traces of exogenous DNA in their wake. Other methods involve the introduction of naked DNA into the cell, which results in insertion into the genome at very low frequencies, usually at random, limiting this approach to organisms that can be economically cultivated at high densities and screened in large numbers. Simply put, most techniques for genetic manipulation are random, inefficient and leave a 'footprint' of foreign DNA. While this is usually tolerated in basic research, it is not acceptable for most commercial applications, and has been a major hurdle for GM animal technologies to date.
The advent of zinc finger nuclease (ZFN) technology represents a significant breakthrough for commercialisation of GM animal products, offering precisely targeted, efficient genome editing for the first time. Commercially available through Sigma Life Science under the CompoZr brand, this technique can be used to create permanent and heritable changes to an organism of interest.
This high degree of variability offers enormous potential for the textiles industry, raising the possibility of tailoring the properties of silk to create advanced technical fabrics
ZFNs are a class of engineered DNA binding proteins that facilitate targeted editing of the genome by creating double-strand breaks at user-specified locations. These breaks stimulate the cell's natural DNA repair mechanisms - homologous recombination (HR) and non-homologous end joining (NHEJ) - which can be exploited to achieve rapid and permanent site-specific modification of the desired genes. While HR can be used to insert foreign DNA sequences, NHEJ allows the cell's natural processes to create precisely targeted mimics of natural mutations which leave no traces of foreign DNA. Unlike previous techniques, ZFNs offer excellent sequence specificity, binding 24 to 36 base pair target sequences to virtually eliminate off target effects, and are able to achieve modification rates exceeding 20 %, well above rates for most other technologies.
The technique is already being used to create transgenic silkworms for spider silk production. By allowing precisely targeted insertion of spider genes and concomitant removal of endogenous silkworm silk genes at the same locus, ZFN technology offers the potential for development of transgenic silkworms which will produce native spider silk at commercially viable levels.
GM technologies have revolutionised the research world and have great potential in a variety of commercial applications, but have been limited by the inherent restrictions associated with historical GM technologies. The main drawback of these technologies is their inability to accurately and efficiently target genes of interest, instead relying on random insertion of genetic material into host genomes. These limitations result in the need for extensive and costly screening to identify animals with correct transgene expression (without compromising the viability of the animal), and also result in the co-expression of both the transgene and native homologues already present.
The advent of ZFN technology signifies the beginning of an exciting new chapter in the world of genetic modification, allowing precise, targeted and efficient genome editing for the first time. Production of native spider silk using transgenic silkworms is just one example of the potential commercial applications of this innovative technology, taking us one step closer to the reality of industrial scale biomanufacturing and paving the way for an entirely new spectrum of environmentally friendly materials.
Authors:
Joseph Bedell and Brian Buntaine
Commercial Animal Technologies Group, Sigma Advanced Genetic Engineering (SAGE) Labs, Sigma Life Science
HEADLINES FOR KRAIG BIOCRAFT LABORATORIES / (KBLB):
PHOTOS FROM VIETNAM POSTED JULY 6, 2018
ANN ARBOR, Mich., – January 7, 2019 –Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, announces today that it has successfully delivered the first two shipments of its highly specialized silkworms, which produce a silk with the physical characteristics of spider silk, to Vietnam.
Today’s announcement is the culmination of more than 5 years of work, and challenging negotiation, with the government of Vietnam. The silkworms from these first two shipments have already hatched and are now enjoying a fresh mulberry diet, so, for the first time in history, the global demand for spider silk materials has a viable, cost effective, and scalable solution.
“The dream of commercializing our powerful technology is now materializing. This marks a dramatic leap forward in Kraig Labs’ business plan for commercial production and mass marketing of cost effective recombinant spider silk, and becomes the foundation for an entirely new industry,” said, COO, Jon Rice. “To our long-term shareholders, who have taken this journey with us, as well as our team in the US and Vietnam, who have worked tirelessly to make this dream a reality, I cannot thank you enough. As we start the New Year, full of new opportunity, we truly have something incredible to celebrate.”
The Company has been working with leading sericulture experts, biotechnology institutions, and governmental agencies, in Vietnam, to further boost the silk industry with our revolutionary technology. Kraig Labs is currently finalizing renovation plans for a ~46,000 square foot production factory in Quang Nam Province, Vietnam.
“Our plan has always been to bring our technology to the silk producing regions of the world for rapid scale-up,” said, CEO and Founder, Kim Thompson. “Today we see the fruits of that effort. With its massive silk infrastructure and production capacity, Vietnam is an ideal location to launch our technology scale-up. Congratulations to our team and shareholders, as we prepare for the realization of large scale production.”
\
\
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |